{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:58:28Z","timestamp":1785344308220,"version":"3.55.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","funder":[{"name":"National Institute of Child Health and Human Development","award":["UG1 HD40485, U24 HD36801, UG1 HD27869, UG1 HD40545, UG1 HD40500, UG1 HD34208, UG1 HD53097, UG1 HD27915, UG1 HD68282, UG1 HD40560, UG1 HD68258, UG1 HD40512, UG1 HD40544, UG1 HD68268"],"award-info":[{"award-number":["UG1 HD40485, U24 HD36801, UG1 HD27869, UG1 HD40545, UG1 HD40500, UG1 HD34208, UG1 HD53097, UG1 HD27915, UG1 HD68282, UG1 HD40560, UG1 HD68258, UG1 HD40512, UG1 HD40544, UG1 HD68268"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate whether hypoglycemia in neonates born to mothers at risk for late preterm delivery was related to adverse effects on childhood neurodevelopment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      This was a prospective follow-up study of children aged 6 years or older whose mothers were enrolled in the Antenatal Late Preterm Steroids multicenter randomized trial. The study was conducted at 13 centers that participated in the Maternal-Fetal Medicine Units Network cycle from 2011 to 2016. Follow-up was from 2017 to 2022. Adult consent and child assent were obtained. The primary exposure was\n                      <jats:italic toggle=\"yes\">hypoglycemia<\/jats:italic>\n                      , defined as a blood glucose concentration less than 40 mg\/dL within 24 hours of birth. The primary outcome, proportion of GCA (General Conceptual Ability) scores lower than 85 (\u22121 SD) from the DAS-II (Differential Ability Scales, 2nd Edition), was analyzed by the presence of hypoglycemia at birth, irrespective of initial trial treatment assignment (betamethasone or placebo). Secondary outcomes included GMFCS (Gross Motor Function Classification System) level, SRS-2 (Social Responsiveness Scale, 2\n                      <jats:sup>nd<\/jats:sup>\n                      Edition) scores, and CBCL (Child Behavior Checklist) scores. Univariable and multivariable analyses were performed, the latter adjusted for prespecified variables known to be associated with the primary outcome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Of 1,026 children enrolled, 1,020 (99.4%) had blood glucose data and 944 had data for the primary outcome. Of these 944, 785 (83.2%) were delivered late preterm and 208 (22.0%) had hypoglycemia, of whom 84 (40.4%) were treated. Those with hypoglycemia were more likely to have private insurance, have older mothers, receive betamethasone, and identify as White. There were no differences in the primary outcome, GCA score lower than 85 (15.9% in those with hypoglycemia vs 18.5% in those without; adjusted relative risk 1.03; 95% CI, 0.74\u20131.45), and no difference in secondary outcomes. Severity of hypoglycemia also was not associated with any outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>In our cohort, hypoglycemia was not associated with neurodevelopmental outcomes in children born predominantly late preterm.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006366","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:00:09Z","timestamp":1784239209000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Child Neurodevelopmental Outcomes After Late Preterm Hypoglycemia"],"prefix":"10.1097","author":[{"given":"Cynthia","family":"Gyamfi-Bannerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"de Voest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T. N.","family":"Tita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean C.","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca G.","family":"Clifton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Michael","family":"O'Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine Z.","family":"Bousleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felecia","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight J.","family":"Rouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torri D.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Saade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara M.","family":"Rood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent D.","family":"Heyborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Thorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta K.","family":"Swamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Grobman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly S.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser Y.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Macones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"R1-20260729","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1542\/peds.2010-3851","article-title":"Postnatal glucose homeostasis in late-preterm and term infants","volume":"127","author":"Adamkin","year":"2011","journal-title":"Pediatrics"},{"key":"R2-20260729","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/000992289703601201","article-title":"Neonatal hypoglycemia, part I: background and definition","volume":"36","author":"Halamek","year":"1997","journal-title":"Clin Pediatr (Phila)"},{"key":"R3-20260729","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1055\/s-0041-1729561","article-title":"Evaluation of hypoglycemia in neonates of women at risk for late preterm delivery: an antenatal late preterm steroids trial cohort study","volume":"40","author":"Gyamfi-Bannerman","year":"2023","journal-title":"Am J Perinatol"},{"key":"R4-20260729","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.clp.2006.10.001","article-title":"Glucose metabolism in the late preterm infant","volume":"33","author":"Garg","year":"2006","journal-title":"Clin Perinatol"},{"key":"R5-20260729","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","article-title":"Antenatal betamethasone for women at risk for late preterm delivery","volume":"374","author":"Gyamfi-Bannerman","year":"2016","journal-title":"N Engl J Med"},{"key":"R6-20260729","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2024.4303","article-title":"Neurodevelopmental outcomes after late preterm antenatal corticosteroids: the ALPS follow-up study [published erratum appears in JAMA 2025;333:1460]","volume":"331","author":"Gyamfi-Bannerman","year":"2024","journal-title":"JAMA"},{"key":"R7-20260729","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1362361313500382","article-title":"Confirmatory factor analytic structure and measurement invariance of quantitative autistic traits measured by the Social Responsiveness Scale-2","volume":"18","author":"Frazier","year":"2014","journal-title":"Autism"},{"key":"R9-20260729","doi-asserted-by":"crossref","first-page":"e2235989","DOI":"10.1001\/jamanetworkopen.2022.35989","article-title":"Neurocognitive outcomes at age 2 years after neonatal hypoglycemia in a cohort of participants from the hPOD randomized trial","volume":"5","author":"Edwards","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R10-20260729","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jamapediatrics.2017.1579","article-title":"Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years","volume":"171","author":"McKinlay","year":"2017","journal-title":"JAMA Pediatr"},{"key":"R11-20260729","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12884-024-06851-y","article-title":"A comparison of short- and long-term prognoses between cases with and without antenatal corticosteroid administration in late preterm delivery: a nationwide population-based study","volume":"25","author":"Cho","year":"2025","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:00:32Z","timestamp":1785340832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":10,"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006366","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"2026-02-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}